Phase 2 Stroke Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are admitted to hospital and have been diagnosed with an acute ischemic stroke (a stroke caused by a blocked blood vessel in the brain)
- People whose stroke symptoms match a specific pattern described in Traditional Chinese Medicine (TCM) called "phlegm-heat syndrome" (confirm with trial site)
- People whose brain scan (MRI) results or risk factor profile suggest they are at higher risk of their stroke symptoms getting worse in the early stages
- People whose stroke started within the last 48 hours
- People aged between 18 and 80 years old, of any gender
- People (or their representative) who have signed a consent form agreeing to take part
Who may not be able to join:
- People who have received, or are planned to receive, clot-dissolving medication or a procedure to open the blocked blood vessel
- People whose stroke may have been caused by a brain tumour, head injury, or a blood disorder, rather than a typical ischemic stroke
- People who already needed significant help with daily activities before this stroke occurred
- People who have a condition affecting their movement, such as severe joint disease
- People with known serious liver or kidney problems, based on blood test results
- People with severe difficulty speaking or a serious mental illness that would affect their ability to participate in assessments
- People who are pregnant, possibly pregnant, or breastfeeding
- People who are currently taking part in another clinical trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The incidence of early neurological deterioration within 7 days of onset
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.